Buy & Sell Eli Lilly And Co (LLY) – Eli Lilly And Co Price Today
Aura AI Summary
Key Stats
- $880.19BMarket Cap
- HealthSector
- -19.59%3M Drawdown
- $918.28BEnterprise Value
- 0.7%Dividend Yield
- 31% Buy | 69% SellTrading Activity
- 89 daysTypical Hold Time
Eli Lilly And Co (LLY) is currently valued at a market capitalization of $880.19B, with an enterprise value of $918.28B. Over the past 52 weeks, Eli Lilly And Co has traded between a low of $625.65 and a high of $1,109.94, highlighting its annual price range. Over the past three months, Eli Lilly And Co has recorded a drawdown of -19.59%, reflecting recent price volatility. Eli Lilly And Co offers a dividend yield of 0.7%, with the most recent dividend of $1.73 paid on 13 Feb 26. On average, investors hold Eli Lilly And Co for approximately 89 days, indicating typical investor behavior on the platform.
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Most Recent News
Tarsus Pharmaceuticals to present at three investor conferences in May 2026
Tarsus Pharmaceuticals announced its management will participate in three upcoming investor conferences in May 2026: Bank of America Securities Health Care Conference on May 12, H.C. Wainwright BioConnect Investor Conference on May 19, and Stifel Vir...
Oil prices drop below $100 while gasoline prices hit highest since 2022, boosting refiners' profits.
Crude oil prices fell below $96 a barrel amid ceasefire talks, but gasoline prices rose to $4.56 per gallon, the highest since summer 2022. This divergence is driving refining profit margins, measured by the 3-2-1 crack spread, to a near-record $56.2...
Acumen Pharmaceuticals to present at Bank of America 2026 Health Care Conference on May 14.
Acumen Pharmaceuticals, a clinical-stage biotech company focused on Alzheimer's disease treatments, will participate in a fireside chat at the Bank of America Securities 2026 Health Care Conference on May 14, 2026. The company is advancing its lead d...